Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As of now, the world is battling Covid-19. The name “Covid-19” says “Corona Virus Disease -2019” as the first traces were found in human body in 2019.
The term “Corona Virus” is coined regarding the family of viruses that get transmitted between humans and animals. As such, they are also called “zoonotic viruses”.
By the end of Mar 2020, the WHO confirmed that Covid-19 outbreak has spread to 213 countries across 6 continents.
The common symptoms observed are dry cough, fatigue, fever, sore throat, shortness of breath, body pain/ache, and even diarrhea in a few cases. At times, runny nose and nausea are also observed.
Till recently, this infection was reported to spread from person to person through saliva or nasal discharge, especially on the infected person sneezing or coughing. However, of late, WHO issued guidelines for airborne transmission as well. The time between a person getting exposed to Covid-19 and onset of symptoms is usually 12-14 days.
RT PCR (Reverse Trascriptase PCR) remains the preferred mode of treatment for coronavirus testing. This technique is advantageous such that primers used can be produced with utmost speed.
As such, multiplex RT PCR is the most preferred diagnostic test with regards to Covid-19. Many molecular diagnostics companies are focusing on developing affordable RT PCR tests.
Along the above-mentioned lines, efforts are being taken by certain players to cater to the increasing number of Covid-19 affected patients. They are likely to substantiate the Covid-diagnostics market in the forecast period (2020-2030).
For instance –
Principal Consultant
Apart from the market players, educational and research institutes are putting their best foot forward to develop safer and quicker coronavirus diagnostic test kits.
For instance –
Recently, several people who had shown no symptoms of Covid-19 have been reported to have contracted Covid-19. This has actually put the healthcare personnel in a fix, as there is no way out other than mass testing.
To enable this testing at a large scale, Covid-19 testing kits also need to be available in large numbers. For instance – Roche’s testing head mentioned that demand for equipment for processing Covid-19 tests has increased to the levels it would normally see over 4 to 5 years.
On these grounds, the company is planning to introduce novel antibody tests by the end of 2020 to widen its offering pertaining to the same.
Moreover, local players across the globe are trying their best to table Covid-19 test kits, so that detection gets speeded up and so do the medications. For instance – In Apr 2020, FastSense Diagnostics, an India-based start-up, developed rapid diagnostic kits to screen Covid-19.
Similarly, South Korea-based SD Biosensor, in Apr 2020, obtained the license to produce Covid-19 test kits in India. Also, Voxtur Bio, around the same time, started manufacturing rapid test kits to address Covid-19.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Covid-19 pandemic has taken the entire world on a ride. As of now, the US, Russia, Italy, Spain, Brazil, India, Australia are amongst the worst affected countries. As such, North America, Europe, Latin America, Oceania, Asia-Pacific – all the continents are battling Covid-19. Right now, there are 14,971,036 confirmed cases, inclusive of 618,017 deaths, as reported by the WHO.
Americas is top-seeded with 7,948,513, Europe stands second with 3,124,701, and South-East Asia with 1,571,317 confirmed cases. So, Americas are requiring the highest number of Covid-19 test kits. The status quo is expected to remain the same in the subsequent quarters as it will definitely take time for Covid-19 to reach the “below par” mark.
Also, Switzerland and Czech Republic have increasing testing capacity on their part in the last few months. As far as Asia Pacific is concerned, profitable partnership initiatives amongst India, South Korea, Japan regarding penetration of Covid-19 diagnostic products are expected to bolster the market
The key players are into accelerating production as well as supply of Covid-10 diagnostic test kits for keeping pace with requirement for disease containment. For example – Roche, in Mar 2020, did initiate shipment of Cobas SARS-CoV-2 test kits’ first allotment.
Around 400,000 test kits were shipped all across the US hospitals and reference laboratories. Likewise, it started shipping additional 400,000 additional test kits every week.
Likewise, the players are working on collaborative approach to cope with Covid-19 crisis and also expand business. For instance, Quest Diagnostics, in May 2020, collaborated with Ortho Clinical Diagnostics with the objective of expanding Covid-19 testing across 20+ labs all through the US. Ortho’s VITROS Immunodiagnostic products Anti-SARS-CoV-2 IgG test for speeding up Covid-19 testing in the patients.
The other major players include:
The Covid-19 diagnostics market is expected to go strong in the upcoming period. Even when a vaccine is eventually developed, testing will still be around, as inoculating entire population will take time.
The market players are already on to the expansion spree in terms of production of diagnostic kits. However, they need to devise ways to mellow down on the costs, which is one of the most competitive factors for them at the global level. The local players are already giving them a tough fight in this regard.
Product Type
Sample Type
Technology
Region
The covid-19 diagnostics market is likely to secure a CAGR of 7.7% through 2032.
The covid-19 diagnostics market size is estimated to cross US$ 204.51 Bn by 2032.
The covid-19 diagnostics market is likely to record a value of US$ 97.4 Bn in 2022.
Europe is likely to lead the covid-19 diagnostics market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Technology Adoption / Usage Analysis
4.2. Key Product Features and their USPs
4.3. Key Promotional Strategies, By Manufacturers
4.4. Regulations, By Region
5. Global Market (Volume in Units) Analysis 2015-2019 and Forecast, 2020-2030
5.1. Historical Market Volume (in Units) Analysis, 2015-2019
5.2. Current and Future Market Volume (in Units) Projections, 2020-2030
6. Global Market - Pricing Analysis
6.1. Average Pricing Analysis By Region
6.2. Pricing Break-up
6.2.1. Manufacturer Level Pricing
6.2.2. Distributor Level Pricing
6.3. Global Average Pricing Analysis Benchmark
7. Global Market Demand (Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Per Capita Healthcare Expenditure Outlook
8.2. Forecast Factors - Relevance & Impact
8.2.1. Increase in R&D Funding and Grants
8.2.2. Increase in Number of Corona Virus Disease Cases
8.2.3. Diagnosis Seeking Rate
8.2.4. COVID-19 Disease Mortality Rate
8.2.5. Industry Consolidation to Increase Capacity
8.2.6. Increase in Manufacturing Activity
8.3. Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Opportunity Analysis
8.4. COVID19 Crisis Analysis
8.4.1. Current COVID19 Statistics and Probable Future Impact
8.4.2. Current GDP Projection and Probable Impact
8.4.3. Current Economic Projection as compared to 2008 Economic analysis
8.4.4. COVID19 and Impact Analysis
8.4.4.1. Revenue By Product Type
8.4.4.2. Revenue By Sample Type
8.4.4.3. Revenue By Technology
8.4.4.4. Revenue By End User
8.4.4.5. Revenue By Country
8.4.5. 2020 Market Scenario
8.4.6. Quarter by Quarter Forecast
8.4.7. Projected recovery Quarter
8.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact
9. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2015-2019
9.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Product Type, 2020-2030
9.3.1. Instruments
9.3.2. Test Kits
9.3.2.1. Rapid Test Kits
9.3.2.2. Assay Based Test Kits
9.3.3. Reagents and Consumables
9.4. Market Attractiveness Analysis By Product Type
10. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Sample Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By Sample Type, 2015-2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample Type, 2020-2030
10.3.1. Oropharyngeal & Nasopharyngeal Swabs
10.3.2. Blood
10.3.3. Urine
10.3.4. Others
10.4. Market Attractiveness Analysis By Sample Type
11. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Technology
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015-2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2020-2030
11.3.1. PCR
11.3.2. ELISA
11.3.3. POC
11.4. Market Attractiveness Analysis By Technology
12. Global Market Analysis 2015-2019 and Forecast 2020-2030, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
12.3.1. Hospitals
12.3.2. Speciality Clinics
12.3.3. Diagnostic Centers
12.3.4. Pathology Laboratories
12.3.5. Research Institutes
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) & Volume Analysis By Region, 2015 - 2019
13.3. Current Market Size (US$ Mn) & Volume Analysis and Forecast By Region, 2020 - 2030
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
14.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product Type
14.3.3. By Sample Type
14.3.4. By Technology
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
15.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product Type
15.3.3. By Sample Type
15.3.4. By Technology
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
16.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product Type
16.3.3. By Sample Type
16.3.4. By Technology
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
17.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product Type
17.3.3. By Sample Type
17.3.4. By Technology
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
18.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product Type
18.3.3. By Sample Type
18.3.4. By Technology
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
19.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product Type
19.3.3. By Sample Type
19.3.4. By Technology
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2015-2019 and Forecast 2020-2030
20.1. Introduction
20.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
20.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. Rest of Middle East and Africa
20.3.2. By Product Type
20.3.3. By Sample Type
20.3.4. By Technology
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Key and Emerging Countries Market Analysis 2015-2019 and Forecast 2020-2030
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. Market Analysis
21.2.1. By Product Type
21.2.2. By Sample Type
21.2.3. By Technology
21.2.4. By End User
21.3. Canada Market Analysis
21.3.1. By Product Type
21.3.2. By Sample Type
21.3.3. By Technology
21.3.4. By End User
21.4. Mexico Market Analysis
21.4.1. By Product Type
21.4.2. By Sample Type
21.4.3. By Technology
21.4.4. By End User
21.5. Brazil Market Analysis
21.5.1. By Product Type
21.5.2. By Sample Type
21.5.3. By Technology
21.5.4. By End User
21.6. U.K. Market Analysis
21.6.1. By Product Type
21.6.2. By Sample Type
21.6.3. By Technology
21.6.4. By End User
21.7. Germany Market Analysis
21.7.1. By Product Type
21.7.2. By Sample Type
21.7.3. By Technology
21.7.4. By End User
21.8. France Market Analysis
21.8.1. By Product Type
21.8.2. By Sample Type
21.8.3. By Technology
21.8.4. By End User
21.9. Italy Market Analysis
21.9.1. By Product Type
21.9.2. By Sample Type
21.9.3. By Technology
21.9.4. By End User
21.10. Spain Market Analysis
21.10.1. By Product Type
21.10.2. By Sample Type
21.10.3. By Technology
21.10.4. By End User
21.11. BENELUX Market Analysis
21.11.1. By Product Type
21.11.2. By Sample Type
21.11.3. By Technology
21.11.4. By End User
21.12. Russia Market Analysis
21.12.1. By Product Type
21.12.2. By Sample Type
21.12.3. By Technology
21.12.4. By End User
21.13. China Market Analysis
21.13.1. By Product Type
21.13.2. By Sample Type
21.13.3. By Technology
21.13.4. By End User
21.14. Japan Market Analysis
21.14.1. By Product Type
21.14.2. By Sample Type
21.14.3. By Technology
21.14.4. By End User
21.15. South Korea Market Analysis
21.15.1. By Product Type
21.15.2. By Sample Type
21.15.3. By Technology
21.15.4. By End User
21.16. India Market Analysis
21.16.1. By Product Type
21.16.2. By Sample Type
21.16.3. By Technology
21.16.4. By End User
21.17. ASEAN Market Analysis
21.17.1. By Product Type
21.17.2. By Sample Type
21.17.3. By Technology
21.17.4. By End User
21.18. Australia Market Analysis
21.18.1. By Product Type
21.18.2. By Sample Type
21.18.3. By Technology
21.18.4. By End User
21.19. New Zealand Market Analysis
21.19.1. By Product Type
21.19.2. By Sample Type
21.19.3. By Technology
21.19.4. By End User
21.20. GCC Countries Market Analysis
21.20.1. By Product Type
21.20.2. By Sample Type
21.20.3. By Technology
21.20.4. By End User
21.21. Turkey Market Analysis
21.21.1. By Product Type
21.21.2. By Sample Type
21.21.3. By Technology
21.21.4. By End User
21.22. South Africa Market Analysis
21.22.1. By Product Type
21.22.2. By Sample Type
21.22.3. By Technology
21.22.4. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Concentration
22.3. Market Share Analysis of Top Players
22.4. Market Presence Analysis
22.4.1. By Regional footprint of Players
22.4.2. Product foot print by Players
22.4.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. Thermo Fisher Scientific, Inc.
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
23.3.1.4. Sales Footprint
23.3.1.5. Strategy Overview
23.3.1.5.1. Marketing Strategy
23.3.1.5.2. Product Strategy
23.3.1.5.3. Channel Strategy
23.3.2. Danaher
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
23.3.2.4. Sales Footprint
23.3.2.5. Strategy Overview
23.3.2.5.1. Marketing Strategy
23.3.2.5.2. Product Strategy
23.3.2.5.3. Channel Strategy
23.3.3. F. Hoffman-La Roche Ltd.
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
23.3.3.4. Sales Footprint
23.3.3.5. Strategy Overview
23.3.3.5.1. Marketing Strategy
23.3.3.5.2. Product Strategy
23.3.3.5.3. Channel Strategy
23.3.4. Hologic Inc.
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
23.3.4.4. Sales Footprint
23.3.4.5. Strategy Overview
23.3.4.5.1. Marketing Strategy
23.3.4.5.2. Product Strategy
23.3.4.5.3. Channel Strategy
23.3.5. Laboratory Corporation of America Holdings
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
23.3.5.4. Sales Footprint
23.3.5.5. Strategy Overview
23.3.5.5.1. Marketing Strategy
23.3.5.5.2. Product Strategy
23.3.5.5.3. Channel Strategy
23.3.6. Luminex Corporation
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
23.3.6.4. Sales Footprint
23.3.6.5. Strategy Overview
23.3.6.5.1. Marketing Strategy
23.3.6.5.2. Product Strategy
23.3.6.5.3. Channel Strategy
23.3.7. Mylab Discovery Solutions Pvt Ltd.
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
23.3.7.4. Sales Footprint
23.3.7.5. Strategy Overview
23.3.7.5.1. Marketing Strategy
23.3.7.5.2. Product Strategy
23.3.7.5.3. Channel Strategy
23.3.8. Neuberg Diagnostics
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
23.3.8.4. Sales Footprint
23.3.8.5. Strategy Overview
23.3.8.5.1. Marketing Strategy
23.3.8.5.2. Product Strategy
23.3.8.5.3. Channel Strategy
23.3.9. Perkin Elmer, Inc.
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
23.3.9.4. Sales Footprint
23.3.9.5. Strategy Overview
23.3.9.5.1. Marketing Strategy
23.3.9.5.2. Product Strategy
23.3.9.5.3. Channel Strategy
23.3.10. Quest Diagnostics
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
23.3.10.4. Sales Footprint
23.3.10.5. Strategy Overview
23.3.10.5.1. Marketing Strategy
23.3.10.5.2. Product Strategy
23.3.10.5.3. Channel Strategy
23.3.11. Quidel Corporation
23.3.11.1. Overview
23.3.11.2. Product Portfolio
23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
23.3.11.4. Sales Footprint
23.3.11.5. Strategy Overview
23.3.11.5.1. Marketing Strategy
23.3.11.5.2. Product Strategy
23.3.11.5.3. Channel Strategy
23.3.12. Merck KGaA
23.3.12.1. Overview
23.3.12.2. Product Portfolio
23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
23.3.12.4. Sales Footprint
23.3.12.5. Strategy Overview
23.3.12.5.1. Marketing Strategy
23.3.12.5.2. Product Strategy
23.3.12.5.3. Channel Strategy
23.3.13. Veredus Laboratories
23.3.13.1. Overview
23.3.13.2. Product Portfolio
23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
23.3.13.4. Sales Footprint
23.3.13.5. Strategy Overview
23.3.13.5.1. Marketing Strategy
23.3.13.5.2. Product Strategy
23.3.13.5.3. Channel Strategy
23.3.14. Abbott Laboratories
23.3.14.1. Overview
23.3.14.2. Product Portfolio
23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
23.3.14.4. Sales Footprint
23.3.14.5. Strategy Overview
23.3.14.5.1. Marketing Strategy
23.3.14.5.2. Product Strategy
23.3.14.5.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Explore Healthcare Insights
View Reports
Covid-19 Diagnostics Market
